Trial Profile
Expanded Access for Hereditary Angioedema (HAE)
Status:
Completed
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 09 May 2019
Price :
$35
*
At a glance
- Drugs Complement C1 inhibitor protein (Primary)
- Indications Hereditary angioedema
- Focus Expanded access; Therapeutic Use
- 27 Jul 2017 Status changed from recruiting to completed.
- 08 Jun 2017 New trial record